Production (Stage)
Allarity Therapeutics, Inc.
ALLR
$1.03
-$0.035-3.29%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 63.34% | 35.69% | -611.48% | 57.61% | -123.17% |
| Total Depreciation and Amortization | 1,000.00% | -80.00% | 400.00% | -50.00% | -77.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -45.88% | -96.34% | 561.90% | -352.36% | 87.05% |
| Change in Net Operating Assets | -103.81% | 223.76% | 11.72% | -223.83% | -16.99% |
| Cash from Operations | 16.22% | 41.10% | 24.57% | -415.80% | 16.33% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | 163.12% | -22.01% | -80.36% | 69,022.50% | -92.35% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | 100.00% | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 163.12% | -13.00% | -81.50% | 1,806.45% | 164.37% |
| Foreign Exchange rate Adjustments | -184.37% | 273.85% | -13.37% | -204.24% | 298.80% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 663.64% | 238.96% | -104.07% | 12,859.59% | 111.84% |